Bionano, a company dedicated to advancing genomics and genome biology, has successfully raised $30,000,000 in funding. This financial boost will allow Bionano to continue its groundbreaking work in areas such as cancer research, human disease understanding, agricultural bioengineering, and genome discovery. The company's innovative next-generation genome mapping and analysis tools, like Saphyrâ„¢, provide researchers with unparalleled structural variation discovery capabilities and the ability to create highly accurate and comprehensive genome assemblies. Bionano's commitment to empowering its global community of users with the resources and support needed to drive meaningful advancements in genomics underscores its mission to improve quality of life for all. With this new funding, Bionano is poised to further revolutionize the field of genomics and make significant strides in unlocking the mysteries of the genome.




